Augmentin

Collaborative Urological Prosthetics Investigation Directive Research Group

Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions

Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions

Prophylactic Antibiotic in Non-complicated Low Risk Lap Cholecystectomy (LC)

Effects of Antibiotic Prophylaxis on the Healing Parameters Following Surgical Crown Lengthening

Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Short Duration Treatment of Non-severe Community Acquired Pneumonia

Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis

The Use of Prophylactic Antibiotics In the Management of Dog Bites